Related Experiment Video
Updated: Jan 31, 2026

Lipidico Injection Protocol for Serial Crystallography Measurements at the Australian Synchrotron
Published on: September 23, 2020
Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual
Jan M Bell1, Thomas Gottlieb2, Denise A Daley3
1University of Adelaide, Adelaide, South Australia, Australia.
Abstract:
The Australian Group on Antimicrobial Resistance (AGAR) performs regular period-prevalence studies to monitor changes in antimicrobial resistance in selected enteric Gram-negative pathogens. The 2016 survey was the fourth year to focus on blood stream infections, and included Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter species. Seven thousand five hundred and sixty-five species, comprising Enterobacteriaceae (6,750, 89.2%), P. aeruginosa (723, 9.6%) and Acinetobacter species (92, 1.2%), were tested using commercial automated methods (Vitek 2, BioMérieux; Phoenix, BD) and results were analysed using Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints (January 2017). Of the key resistances, non-susceptibility to the third-generation cephalosporin, ceftriaxone, was found in 11.8%/11.8% of Escherichia coli (CLSI/EUCAST criteria) and 7.7%/7.7% of Klebsiella pneumoniae, and 11.1%/11.1% K. oxytoca. Non-susceptibility rates to ciprofloxacin were 12.8%/16.3% for E.coli, 3.8%/10.0% for K. pneumoniae, 0.8%/2.1% for K. oxytoca, 1.8%/5.6% for Enterobacter cloacae complex, and 5.5%/9.4% for Pseudomonas aeruginosa. Resistance rates to piperacillin-tazobactam were 3.1%/6.5%, 3.6%/7.1%, 14.1%/14.9%, 19.9%/22.3%, and 5.2%/11.8% for the same 4 species respectively. Twenty-eight isolates were shown to harbour a carbapenemase gene, 14 blaIMP, five blaOXA-23, two blaOXA-48-like, two blaNDM, one blaKPC, one blaGES, three blaIMP+OXA-23.
Insights
The Australian Group on Antimicrobial Resistance (AGAR) 2016 study tracked resistance in Gram-negative pathogens. Key findings show concerning non-susceptibility rates to common antibiotics like ceftriaxone and ciprofloxacin.
Area of Science:
- Clinical Microbiology
- Infectious Diseases
- Antimicrobial Resistance Surveillance
Background:
- The Australian Group on Antimicrobial Resistance (AGAR) conducts periodic surveys to monitor antimicrobial resistance trends.
- Antimicrobial resistance in Gram-negative pathogens poses a significant global health threat, necessitating continuous monitoring.
- Bloodstream infections caused by Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter species are common and can lead to severe outcomes.
Purpose of the Study:
- To report the findings of the 2016 AGAR period-prevalence study on antimicrobial resistance in selected Gram-negative pathogens.
- To assess resistance patterns to key antibiotics, including third-generation cephalosporins, fluoroquinolones, and beta-lactam/beta-lactamase inhibitors.
- To identify the prevalence of carbapenemase genes in the studied bacterial isolates.
Main Methods:
- Analysis of 7,565 bacterial isolates from bloodstream infections, including Enterobacteriaceae, P. aeruginosa, and Acinetobacter species.
- Utilized commercial automated methods (Vitek 2, Phoenix) for antimicrobial susceptibility testing.
- Interpreted results using Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints.
Main Results:
- Non-susceptibility to ceftriaxone was observed in 11.8% of Escherichia coli and 7.7% of Klebsiella pneumoniae.
- Ciprofloxacin non-susceptibility rates varied, with E. coli at 12.8%/16.3% and P. aeruginosa at 5.5%/9.4% (CLSI/EUCAST).
- Twenty-eight isolates harbored carbapenemase genes, including blaIMP, blaOXA-23, blaNDM, and others.
Conclusions:
- The 2016 AGAR study highlights ongoing challenges with antimicrobial resistance in common Gram-negative pathogens in Australia.
- Monitoring resistance to critical antibiotics like ceftriaxone and ciprofloxacin is essential for guiding treatment strategies.
- The presence of carbapenemase genes underscores the need for enhanced surveillance and infection control measures.
Related Concept Videos
Gram-negative Bacterial Protein Secretion Systems
Antimicrobial Effectiveness
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Negative Regulator Molecules

